Publications by authors named "D Troost"

Article Synopsis
  • - Stress granules (SGs) are cellular structures that help manage stalled messenger RNAs and signaling factors during stress, playing a role in coordinating cell growth.
  • - Hsp90, a molecular chaperone, is essential for the dissolution of SGs by stabilizing the kinase DYRK3; when Hsp90 is inhibited, DYRK3 becomes inactive and either enters SGs or gets degraded.
  • - By keeping DYRK3 active, Hsp90 facilitates the disassembly of SGs, which helps restore mTORC1 signaling and protein translation, linking stress response to cell growth.
View Article and Find Full Text PDF

Granulovacuolar degeneration (GVD) occurs in Alzheimer's disease (AD) brain due to compromised autophagy. Endoplasmic reticulum (ER) function and RNA binding protein (RBP) homeostasis regulate autophagy. We observed that the ER chaperones Glucose - regulated protein, 78 KDa (GRP78/BiP), Sigma receptor 1 (SigR1), and Vesicle-associated membrane protein associated protein B (VAPB) were elevated in many AD patients' subicular neurons.

View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is a lethal disease characterized by motor neuron degeneration and associated with aggregation of nuclear RNA-binding proteins (RBPs), including FUS. How FUS aggregation and neurodegeneration are prevented in healthy motor neurons remain critically unanswered questions. Here, we use a combination of ALS patient autopsy tissue and induced pluripotent stem cell-derived neurons to study the effects of FUS mutations on RBP homeostasis.

View Article and Find Full Text PDF
Article Synopsis
  • Amyotrophic lateral sclerosis (ALS) is a leading motor neuron disease characterized by the presence of cytoplasmic fused in sarcoma (FUS) aggregates.
  • Impaired DNA damage response (DDR) signaling from mutations in the FUS nuclear localization sequence (NLS) leads to the mislocalization of FUS in the cytoplasm, contributing to neurodegeneration and aggregate formation.
  • This research highlights the potential of targeting DDR signaling as a new therapeutic approach to treat ALS.
View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) is characterized by the selective degeneration of motor neurons (MNs) and their target muscles. Misfolded proteins which often form intracellular aggregates are a pathological hallmark of ALS. Disruption of the functional interplay between protein degradation (ubiquitin proteasome system and autophagy) and RNA-binding protein homeostasis has recently been suggested as an integrated model that merges several ALS-associated proteins into a common pathophysiological pathway.

View Article and Find Full Text PDF